Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a ...
NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
SAN FRANCISCO -- Moderna announced people may need a second booster to increase protection. But is a fourth shot the right approach? ABC7 News reporter Luz Pena from San Francisco spoke to multiple ...
Moderna has early in-human data showing its next-generation COVID-19 vaccine, mNEXSPIKE, has the potential to offer strong immune protection against the latest rapidly spreading SARS-CoV-2 virus.
CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company’s ...
Stocktwits on MSN
Moderna Procures $1.5B Loan To Grow Its Pipeline Beyond Vaccines
Vaccine maker Moderna (MRNA) said on Thursday that it has secured a $1.5 billion, five-year credit facility from Ares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback